Loading…

Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction

High-sensitivity cardiac troponin assays enable myocardial infarction to be ruled out earlier, but the optimal approach is uncertain. We compared the European Society of Cardiology rule-out pathway with a pathway that incorporates lower cardiac troponin concentrations to risk stratify patients. Pati...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2017-04, Vol.135 (17), p.1586-1596
Main Authors: Chapman, Andrew R, Anand, Atul, Boeddinghaus, Jasper, Ferry, Amy V, Sandeman, Dennis, Adamson, Philip D, Andrews, Jack, Tan, Stephanie, Cheng, Sheun F, D'Souza, Michelle, Orme, Kate, Strachan, Fiona E, Nestelberger, Thomas, Twerenbold, Raphael, Badertscher, Patrick, Reichlin, Tobias, Gray, Alasdair, Shah, Anoop S V, Mueller, Christian, Newby, David E, Mills, Nicholas L
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:High-sensitivity cardiac troponin assays enable myocardial infarction to be ruled out earlier, but the optimal approach is uncertain. We compared the European Society of Cardiology rule-out pathway with a pathway that incorporates lower cardiac troponin concentrations to risk stratify patients. Patients with suspected acute coronary syndrome (n=1218) underwent high-sensitivity cardiac troponin I measurement at presentation and 3 and 6 or 12 hours. We compared the European Society of Cardiology pathway (
ISSN:0009-7322
1524-4539
DOI:10.1161/circulationaha.116.025021